Skip to content

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial.

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial. - A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042024
Enrollment
20
Registered
2020-10-13
Start date
2020-10-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Food containing lactic acid bacteria for 8 weeks Placebo (not containing lactic acid bacteria) for 8 weeks

Sponsors

Lotte Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females from 20 to 59 years of age (2) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals taking antiflatulents and/or laxatives (including purgative drug) and/or drugs which may affect immune function in common use (2) Individuals taking antibiotics and/or drugs which may affect digestion and absorption in common use (3) Individuals taking excessive amounts of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, and/or other health foods including food for specified health use and food with function claim, which influence immune function (4) Individuals presenting known food allergy (5) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (6) Individuals who have previous and/or current medical history of diseases (e.g., diabetes, liver disease, kidney disease, kidney disease) and/or immune-mediated diseases (e.g., atopic dermatitis, asthma, autoimmune disease) (7) Individuals who are under treatment or have a history of drug/alcohol dependence (8) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (9) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Design outcomes

Primary

MeasureTime frame
IgA flow rate of saliva

Secondary

MeasureTime frame
Conditioning questionnaire, concentration of IgA in saliva, saliva flow rate

Countries

Japan

Contacts

Public ContactTomonori Ando

Lotte Co., Ltd. Central Laboratory , Food material development section

andou_tomonori@lotte.co.jp048-837-0187

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026